Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Loutfi S. Aboussouan, MD, FCCP, was born in Beirut, Lebanon. He has been a Staff Physician in the Respiratory Institute of the Cleveland Clinic since 2003, and additionally in the Neurological Institute since 2007.
He is board-certified in pulmonary disease, critical care medicine and sleep medicine. His interests include general pulmonary medicine, chronic obstructive pulmonary disease, neuromuscular diseases, sleep medicine, long-term ventilator care and teaching. He has been the Director of Pulmonary Curriculum for the second-year class of the Cleveland Clinic Lerner School of Medicine since 2006.
Dr. Aboussouan received College Teaching Awards at Wayne State University in Detroit, Mich., in 1999 and 2003, and received the CCLCM preclinical Kaiser Award for Excellence in Teaching in 2014. He has been elected by his peers as one of the Best Doctors in America since 2001. He has been listed in the "Top Docs" issue of Cleveland magazine since 2006.
He has several publications in the fields of pulmonary, neuromuscular, and sleep medicine, and is a reviewer for several scientific journals.
Director of Pulmonary Curriculum for the second-year class of the Cleveland Clinic Lerner School of Medicine since 2006.
Asthma, bronchitis, Chronic Obstructive Pulmonary Disease (COPD), Cough, emphysema, pulmonary disease, neuromuscular disease, sleep medicine
Awards & Honors
College Teaching Awards, Wayne State University, Detroit, Mich.,1999, 2003
CCLCM preclinical Kaiser Award for Excellence in Teaching, 2014
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 2/5/2015, Dr. Aboussouan has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.